Correlation of VEGF expression with prognostic factors of breast carcinoma

Background: Breast carcinoma is the most common malignant tumour and leading cause of cancer death among women worldwide. VEGF being a powerful mediator of angiogenesis, plays a major role in local growth as well as metastasis of many solid tumours including breast carcinoma. Objective: This study a...

Full description

Saved in:
Bibliographic Details
Published inBangladesh journal of medical science (Ibn Sina Trust) Vol. 18; no. 3; pp. 513 - 518
Main Authors Nandi, Jhuma, Maiti, Moumita, Barman, Neepamanjari, Paul, Moumita, Medda, Sreepurna, Ghosal, Sushil Ranjan, Sarkar, Ranu
Format Journal Article
LanguageEnglish
Published Dhaka Ibn Sina Trust 2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: Breast carcinoma is the most common malignant tumour and leading cause of cancer death among women worldwide. VEGF being a powerful mediator of angiogenesis, plays a major role in local growth as well as metastasis of many solid tumours including breast carcinoma. Objective: This study aimed to evaluate the significance of VEGF expression in breast cancer and its correlation with prognostic parameters. Materials and methods: This study was conducted over a period of one year (February 2015 to January 2016). VEGF expression was evaluated in 57 histologically diagnosed cases of breast carcinoma with known ER and HER-2/neu status. Result: Among 57 cases 52(91.2%) were positive for VEGF. Positive ER expression was seen in 39 cases which is 64.8% of total cases. 54% of the total cases were positive for HER-2/neu. VEGF expression was positively correlated (P value <0.05) with tumour grade, tumour size and negatively correlated with ER (p<0.005) and HER-2/neu (p<0.005). Significant correlation also found with tumour type (p<.005). Conclusion: Considering the observations of the current study, it can be concluded that VEGF may play a crucial role in the pathogenesis of breast carcinoma and has a positive correlation with biologically aggressive tumour. So consideration of this biomarker (VEGF) is to be regarded as a prognostic parameter and critical evaluator of targeted chemotherapy Bangladesh Journal of Medical Science Vol.18(3) 2019 p.513-518
ISSN:2223-4721
2076-0299
DOI:10.3329/bjms.v18i3.41619